A new class of synthetic cannabinoids proved exceptionally potent and was linked to deaths

MDMB-4en-PINACA had a potency of 2.47 nM (compared to JWH-018 at 25.3 nM, making it about 10 times more potent) with 239% efficacy. It was identified in 25 forensic toxicology cases including postmortem and impaired driving investigations. The new class of pent-4en and but-3en analogues retained or exceeded the potency and toxicity of previous generations while evading existing drug scheduling.

Combined in vitro CB1 receptor activation assay (beta-arrestin 2 recruitment) for 5 compounds with forensic toxicology case data. Analyzed 25 cases involving MDMB-4en-PINACA across multiple US regions through sample-mining and data-mining.

Synthetic cannabinoids continue to evolve to evade regulation while maintaining or increasing potency. This new class represents a significant public safety threat because they are being sold without any dosing guidance and are far more potent than natural cannabis.

The cat-and-mouse game between synthetic cannabinoid manufacturers and regulators continues to produce increasingly dangerous products. These alkene-modified compounds demonstrate that simple chemical modifications can produce substances that evade scheduling while maintaining lethal potency.

In vitro potency does not directly predict human toxicity. Limited case histories available. Cannot determine exact cause of death in postmortem cases. Detection methods may miss some analogues.